Subscribe to our news feed
A question?
14-05-2024
Getinge's financial target 2024-2028: Adjusted EPS growth of above 12% on average
Getinge updates its financial target for adjusted EPS growth 2024-2028 to be above 12% on average. The target takes into account today’s decisions (see below) that follow from the letter that the U.S. Food and Drug Administration (FDA) sent to healthcare providers in the US on May 8th.
25-04-2024
Getinge’s cGMP washer redefines cleanroom efficiency with compact design and sustainable performance
Today, Getinge unveils the GEW 888 neo, a cGMP washer designed to develop cleanroom efficiency. Built to meet the strictest demands of the biopharmaceutical industry, the GEW 888 neo offers customers the ability to maximize their cleanroom space.
22-04-2024
Getinge Interim Report January-March 2024: Higher sales, strong cash flow and new products creating more customer value
“Net sales increased by 5.2% in the first quarter, of which organic net sales was unchanged despite challenging comparative figures,” says Mattias Perjos, President & CEO at Getinge. “We have a strong free cash flow and a solid financial position that enables investments in profitable growth.”
Press Contacts
Lars Mattsson
Interim EVP Brand & Communication
Phone: +46 10 335 0043
Caroline Örmgård
Head of Public & Media Relations
Phone: +46 10 335 0041
Contact us online
Click below to fill in the appropriate form. We will be in touch shortly.
Are you looking for
Image Gallery
Diverse picture format made available for press article purpose
About us
All you need to know about Getinge a one glance
Urgent Medical Device Correction
Voluntary Urgent Medical Device Field Correction for the CARDIOSAVE intra-aortic balloon pump (IABP)
Don't miss anything
Click on the icons and follow us!